Eli Lilly Promotes Discussion of Alzheimer’s Impact on US Communities at National Mayor’s Conference

Eli Lilly Promotes Discussion of Alzheimer’s Impact on US Communities at National Mayor’s Conference
In an effort to promote education about Alzheimer's disease and help local communities plan for this emerging public health crisis, Eli Lilly and Company has started an expansion of its "Community Conversations on Alzheimer’s" series with a panel discussion at the U.S. Conference of Mayors June 24-27 in Indianapolis. Alzheimer's disease is projected to triple by 2050. As a result, a greater awareness of the economic and social impact of this disease on families, communities, and health systems is extremely urgent. The Community Conversations panel discussion was moderated by Phyllis Ferrell, vice president and head of Eli Lilly’s Global Alzheimer’s Disease Platform Team. The panel debated several topics, including how local governments can prepare for the fiscal and social impact of Alzheimer's together with healthcare and advocacy groups. Panelists included Indianapolis Mayor Joe Hogsett; Randi Chapman, from the Alzheimer’s Association; Malaz Boustani, M.D., professor of medicine and research director at the Indiana Center for Aging Research; and Mike Simmons, DBA, director of Advocacy and Professional Relations at Eli Lilly. "With the prevalence of Alzheimer's in Indiana slated to increase by 18 percent by 2025, the U.S. Conference of Mayors seemed like a critical opportunity to highlight Alzheimer's services and discuss the broader impact this disease has on our communities," Hogsett said in a press release. "Through the
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *